Spray cryotherapy for dysphagia palliation in esophageal cancer prior to systemic therapy: is it ready for prime time?

CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(02): E122-E123
DOI: 10.1055/a-0966-8457

Editorial

Bruce D. Greenwald

University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States

References
1 Tsai FC, Ghorbani S, Greenwald BD. et al. Safety and efficacy of endoscopic spray cryotherapy for esophageal cancer. Dis Esoph 2017; 30: 1
2 Kachaamy T, Prakash R, Kundranda M. et al. Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer. Gastrointest Endosc 2018; 88: 447
3 Aarts BM, Klompenhouwer EG, Rice SL. et al. Cryoablation and immunotherapy: an overview of evidence on its synergy. Insights Imaging 2019; 10: 53
4 Dai Y, Li C, Xie Y. et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 2014; 10: CD005048
5 Shah T, Kushnir V, Mutha P. et al. Neoadjuvant cryotherapy improves dysphagia and may impact remission rates in advanced esophageal cancer. Endosc Int Open 2019; 07: E1522-E1527